{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:36:52Z","timestamp":1788871012377,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"South Korean Ministry of Health and Welfare","award":["A120480-1201-0000100"],"award-info":[{"award-number":["A120480-1201-0000100"]}]}],"content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jocn.2013.12.031","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T05:45:48Z","timestamp":1401169548000},"page":"1661-1664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin A nephropathy"],"prefix":"10.1016","volume":"21","author":[{"given":"Jung-Won","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Hwa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangsup","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ah","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ick","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Il","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kon","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2013.12.031_b0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jemt.1070320405","article-title":"Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis","volume":"32","author":"Aksamit","year":"1995","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.jocn.2013.12.031_b0010","first-page":"1374","article-title":"Progressive multifocal leukoencephalopathy","volume":"18","author":"Aksamit","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jocn.2013.12.031_b0015","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.12.031_b0020","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","article-title":"Identification and characterization of mefloquine efficacy against JC virus in vitro","volume":"53","author":"Brickelmaier","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jocn.2013.12.031_b0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","article-title":"A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes","volume":"19","author":"Clifford","year":"2013","journal-title":"J neurovirol"},{"key":"10.1016\/j.jocn.2013.12.031_b0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5414\/CPP42701","article-title":"Pharmacokinetics of immunosuppressants: a perspective on ethnic differences","volume":"42","author":"Dirks","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jocn.2013.12.031_b0035","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.clineuro.2012.02.046","article-title":"Pharmacokinetic considerations in the repositioning of mefloquine for treatment of progressive multifocal leukoencephalopathy","volume":"114","author":"Nevin","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jocn.2013.12.031_b0040","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2169\/internalmedicine.51.7631","article-title":"Neuropharmacokinetic heterogeneity of mefloquine in the treatment of progressive multifocal leukoencephalopathy","volume":"51","author":"Nevin","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jocn.2013.12.031_b0045","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2169\/internalmedicine.51.6810","article-title":"Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus","volume":"51","author":"Beppu","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jocn.2013.12.031_b0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2013.01.010","article-title":"Progressive multifocal leukoencephalopathy in an immunocompetent patient","volume":"326","author":"Christakis","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2013.12.031_b0055","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archneurol.2010.157","article-title":"Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis","volume":"67","author":"Schr\u00f6der","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2013.12.031_b0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.47102\/annals-acadmedsg.V41N12p620","article-title":"Progressive multifocal leukoencephalopathy with immune reconstitution inflammatory syndrome (PML-IRIS): two case reports of successful treatment with mefloquine and a review of the literature","volume":"41","author":"Young","year":"2012","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jocn.2013.12.031_b0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2169\/internalmedicine.51.6253","article-title":"Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI study","volume":"51","author":"Naito","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jocn.2013.12.031_b0070","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.clineuro.2011.12.010","article-title":"Efficacy of mefloquine to progressive multifocal leukoencephalopathy initially presented with parkinsonism","volume":"114","author":"Hirayama","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jocn.2013.12.031_b0075","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.2169\/internalmedicine.49.3227","article-title":"Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant","volume":"49","author":"Kishida","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.jocn.2013.12.031_b0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2146\/ajhp110392","article-title":"Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus","volume":"69","author":"Moenster","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jocn.2013.12.031_b0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13365-011-0045-2","article-title":"Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS","volume":"17","author":"McGuire","year":"2011","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jocn.2013.12.031_b0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jnnp.2009.190652","article-title":"Mefloquine in the treatment of progressive multifocal leukoencephalopathy","volume":"82","author":"Gofton","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2013.12.031_b0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jns.2012.11.004","article-title":"Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection","volume":"324","author":"Kobayashi","year":"2013","journal-title":"J Neurol Sci"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T13:12:22Z","timestamp":1689253942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586814001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0967586814001635"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2013.12.031","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin A nephropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2013.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}